Summary. Acute myocardial infarction complicated by cardiogenic shock is one of the main reasons of death in severely ill patients. One of the main indications for intra-aortic balloon counter
Introduction
Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is the principal indication for intra-aortic balloon pump (IABP) or counterpulsation (1) . CS causes cardiac mechanical inability to maintain adequate output. Patients with CS demonstrate clinical signs of low cardiac output and adequate intravascular volume (2) . This mechanical cardiac-assist device signifi cantly increases diastolic and mean blood pressure in the aorta and coronary arteries, while decreasing systolic pressure at the same time, thereby unloading the failing heart. By decreasing left ventricle afterload, IABP reduces left ventricle wall tension and oxygen demands (3, 4) . Some studies demonstrated improved metabolic effects in the myocardium of patients with CS who were treated with aortic counterpulsation (5) . Admittedly, the effi ciency of IABP is proven in many clinical scenarios such as high-risk percutaneous coronary interventions (PCI), unstable angina, CS, cardiac surgery, transplantation, and life-threatening arrhythmias (6) . Multiple studies have suggested benefi ts of IABP in mortality of patients with CScomplicated AMI (4, (7) (8) (9) (10) .
AMI complicated by CS remains a leading cause of death in AMI patients, with a mortality rate as high as 60% to 70% (7, 11, 12) . Previous literature reported the mortality rate of even 80%-90% using only pharmacological treatment (13) (14) (15) . However, contemporary literature suggests that combination of thrombolysis, surgical, invasive procedures including IABP are associated with lower mortality rates. In the Global Utilisation of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial, the use IABP in patients undergoing reperfusion therapy led to a trend toward lower 30-day and 1-year mortality (4) . In a report from the SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) Trial Registry, patients who underwent IABP had a signifi cantly lower mortality rate, especially those who had received concomitant thrombolytic treatment. In particular, those who had received IABP placement and subsequently underwent revascularization with PCI or coronary artery bypass graft (CABG) surgery had dramatically lower in-hospital mortality: 39% vs. 78% (P<0.001) (8) . Recently, the SHOCK trial showed that early revascularization with a high utilization of IABP led to a signifi cant improvement in 6-month and 1-year mortality rates (16, 17) . In 23 180 patients with CS in the National Registry of Myocardial Infarction 2 (NRMI-2), the use of IABP in conjunction with thrombolytic therapy decreased the odds of death by 18% (7) . Analysis of the Benchmark Registry indicated that patients who received IABP in association with surgery or PCI had a lower in-hospital mortality compared with patients treated only medically (18.8% vs. 32.5%) (16) .
Aortic counterpulsation has been associated with the risk of several important complications. Although the incidence of these complications is diffi cult to determine because of differing defi nitions, they are most likely decreasing as techniques, equipment, and experience improve (6) .
Over the last several decades, there has been a dramatic improvement in technology and refi nement in percutaneous insertion techniques. These advancements have lowered the incidence of major complications directly associated with IABP (6 (18, 20) . Contemporary large studies demonstrate considerably lower rates of complications: ischemia, 0.5%-5.6%; bleeding, 0.8%-4.6%; infection, 0.1%-0.5%; IABP-related death, 0.05%-0.5%; and IABP failure, 1.2%-2.8%. Studies reporting complication rates are diverse in terms of the indications for IABP, the technique used for insertion, the duration of use, and the specifi c defi nition of a complication (1, 19, (21) (22) (23) (24) (25) .
Obviously, these rates of IABP-related complications are decreasing. However, the complication rate of myocardial infarction is increasing, making us consider how to improve the survival of patients with AMI complicated by CS. It is clear that previously the research of complications of such character was unnecessary because of high mortality. Therefore, the rates of these complications and the clinical course of myocardial infarction using IABP are unstudied.
The aim of the study was to analyze the course of acute myocardial infarction complicated by CS in patients managed by IABP as well as to determine IAB-related complications.
Material and Methods
The retrospective data analysis of patients who experienced AMI, complicated by CS, and were managed by IABP was carried out. All these patients were admitted within 12 hours from the onset of pain. Patients were selected for the investigation in the Cardiology Intensive Care Unit, Department of Cardio logy, Lithuanian University of Health Sciences, during the period of 2006-2010. A total of 73 patients -30 women (41.1%) and 43 men (58.9%) -were included into the study. The mean age was 70.5 years (SD, 2.8). The balloon was inserted under local anesthesia. The balloons ranged from 7.5 French (F) to 9.5 F. A total of 73 patients underwent percutaneous balloon insertion with the "sheath-less technique" (26) . Frequency and character of myocardial infarction-related complications were analyzed. Additionally, complications directly associated with IABP were studied. The success of revascularization was assessed according to the TIMI grade fl ow angiographic criteria. Angiographic success of revascularization was defi ned as an improvement in blood fl ow of coronary artery after revascularization comparing with blood fl ow grade before intervention.
Statistical analysis was performed by using software STATISTICA, version 8.0. Data are expressed as mean (SD). The Student t test was used for parametric samples. A value of P<0.05 was considered statistically signifi cant. Stepwise logistic regression was performed to determine the independent correlates of in-hospital mortality, considering age, previous MI, performance of PCI, duration of counterpulsation in the model.
Results
The average duration from the onset of pain to hospitalization was 7.9 hours (SD, 6. The clinical conditions, which were observed before initiation of IABP, are shown in the Table  1 . The most common noncardiac complications, associated with systemic infl uence of failing heart, and direct IABP-related complications are presented in Table 2 .
In-hospital death occurred in 33 patients (45%) with IABP. The independent predictors of mortality in patients with AMI requiring IABP placement are shown in Table 3 . The patients who experienced acute renal failure (ARF) were not older in comparison with patients whose renal function remained normal, and the mean duration of IABP application was not longer for patients suffering ARF (Fig.) .
Primary PCI was successful in 47 patients (81%) and unsuccessful in 11 (19%) . The positive impact of successful PCI was observed for some complications and mortality rate. Those who underwent successful revascularization with PCI had a lower mortality rate (16 [34%] vs. 9 [82%] patients, P=0.003) and lower rate of ARF (28% vs. 67%, P=0.002) in comparison with unsuccessful cases after intervention. Thirteen patients with multivessel disease and 2 patients after unsuccessful primary PCI were directed to surgical myocardial revascularization. Mortality rate after surgical revascularization was 53% (8 of the 15 patients), and it was higher comparing with primary PCI (43%). There was a trend toward the lower frequency of ventricular fi brillation in successfully revascularized patients (11% vs. 33%, P>0.05). Moreover, no femoral thrombosis in these patients was observed, whereas there were 2 cases of thrombosis in patients with unsuccessful PCI (P=0.04).
Femoral thrombosis was more commonly observed in patients with ventricular septal defect in comparison with patients with intact septum (25% vs. 0%, 
Discussion
The principal fi ndings of this study were as follows: 1) the main clinical conditions, which were observed before initiation of IABP, were atrial fibrillation and asystolia; 2) the most common noncardiac complication was acute renal failure. ARF was not more frequent in older patients and in cases of longer IABP application; 3) the most common direct IABP-related complication was thrombocytopenia. It may occur with IABP because of the mechanical destruction of platelets and/or heparin administration; 4) successful cases of PCI showed a lower mortality rate in comparison with unsuccessful cases; and 5) mental disorders were not observed.
Performance of IABP. The correct placement of an IABP results in notable augmentation of diastolic blood pressure with no change in heart rate. The Benchmark Registry reports that the mean duration of IABP application is 72 hours. Our study showed that the mean duration of counterpulsation was not much longer (76.9 hours [SD, 33.0]) as compared with that of the Benchmark Registry.
Mortality and Complications of IABP. The IABP Benchmark Registry (27) represents 5495 cases of myocardial infarction. This registry presents a statistical analysis of mortality in patients with AMI. Results show that overall mortality in patients with AMI complicated by CS was 30.7%. The IABP registry data were compared with the results of our study; the mortality rate (45%) in our study was higher than that in the IABP benchmark registry. Moreover, our investigators compared the data with the previous study, which was performed in 2006. The comparison revealed that the mortality rate of counterpulsated patients decreased by 20.25% during 4 years (2). A great improvement was achieved, because the insertion of IABP can be safely performed exclusively by trained medical professionals (28) . Similarly, a recent single institution report showed a signifi cant reduction in in-hospital mortality by 10%-20% during the last 5 years (29, 30) . We would like to point out that IABP per se causes a low percentage of all complications that arise after the application of IABP. As shown in Table 2 , the complications of IABP therapy occurred in 9.6% of patients. This fi gure is very similar to the published rates by most of the other studies (8.1%) (31) . A unique fi nding of this study is a high rate of successful IABP applications: only in 1.4% of cases, IABP was not established due to poor infl ation of balloon. The rate of femoral thrombosis in our study was 2.7% vs. 2.7% in the IABP benchmark registry. There is no doubt that cardiac pump failure due to coronary occlusion plays the main role in early systemic disorder. Moreover, the prolonged shock state induces the development of impaired organ perfusion. The results of our study confi rmed this statement, because the most common noncardiac complication associated with systemic effect of failing heart was ARF. ARF was documented in 53.4% of all cases. IABP duration and patients' age were not related to a higher incidence of ARF. These fi ndings show that the hemodynamic benefi ts of IABP may be achieved in high-risk patient group with relatively low risk (32, 33) .
Use of Revascularization Procedures. The early revascularization strategy after IABP placement in patients with cardiogenic shock is a priority in most centers. Revascularization was performed in more than 85% of AMI patients in the Department of Cardiology, Lithuanian University of Health Sciences. This study shows a positive effect of successful PCI on mortality rate. A considerable difference was seen between patients who received successful revascularization with PCI and unsuccessful cases. Successful cases had a lower mortality rate in comparison with unsuccessful cases (34% vs. 82%, P=0.003). Moreover, a lower rate of ARF after successful PCI was observed (28% vs. 67%, P=0.002). We suppose that this result is caused by improved hemodynamic and aborted development of impaired organ perfusion. Furthermore, we did not fi nd any femoral thrombosis in these patients, whereas there was an 18.2% rate of thrombosis in patients with failed PCI (P=0.005), and similarly there was no difference in the mean duration of IABP in those patients. However, meta-analysis (34) shows that in patients treated with primary PCI, IABP was associated with a 6% increase (95% confi dence interval, 3%-10%; P<0.001) in the 30-day mortality. This meta-analysis yielded unexpected results. Observational data do not support IABP therapy adjunctive to primary PCI. It suggests us to rethink our concept of adjunctive IABP therapy in patients with myocardial infarction complicated by CS after successful PCI. Organization of such a study has been initiated in Germany in 2010 (35) .
Study Limitations. A limitation of this study, however, is that right heart catheterization was not routinely performed before and after IABP application. In addition, pulmonary capillary wedge pressure was not recorded. For this reason, we cannot evaluate if application of IABP resulted in preload reduction.
Conclusions
Intra-aortic balloon counterpulsation might be successfully employed providing signifi cant hemodynamic support with rare major complications in a high-risk patient population. The highly successful percutaneous coronary intervention rates in patients managed with intra-aortic balloon counterpulsation decreased the mortality of patients with cardiogenic shock.
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Aortos kontrapulsacija esant kardiogeninio šoko komplikacijoms
ūminio miokardo infarkto metu Raktažodžiai: intraaortinė kontrapulsacija, ūminis miokardo infarktas, kardiogeninis šokas, komplikacijos, perkutaninė vainikinių arterijų intervencija.
Santrauka. Ūminis miokardo infarktas, komplikavęsis kardiogeniniu šoku, yra viena dažniausių sunkių ligonių mirties priežasčių. Mokslinėje literatūroje nurodoma, kad intraaortinė kontrapulsacija pagerina ligonių, kurių būklė komplikavosi kardiogeniniu šoku, baigtis. Intraaortinė kontrapulsacija dažnai siejama su keliomis sunkiomis komplikacijomis: nukraujavimu, tromboze, trombocitopenija, galūnių išemija, aortos sienelės pažeidimu. Manome, kad mokslinis komplikacijų ištyrimas galėtų padėti suprasti ūminio miokardo infarkto eigą, intraaortinė kontrapulsacija leistų sumažinti komplikacijų atsiradimo riziką.
Tyrimo tikslas -ištirti ligonių, sergančių ūminiu miokardo infarktu ir patyrusių kardiogeninio šoko komplikacijas ir kuriems atlikta aortos kontrapulsacija, būklės pokyčius bei nustatyti komplikacijas, atsiradusias po aortos kontrapulsacijos.
Medžiaga ir metodai. Tyrimo metu buvo atlikta retrospektyvioji ligonių duomenų analizė. Į tyrimą įtraukti ligoniai gydyti Lietuvos sveikatos mokslų universiteto Kardiologijos intensyviosios terapijos skyriuje 2004-2010 metais. Tyrimo imtį sudarė 73 ligoniai: 30 (41,1 proc.) moterų ir 43 (58,9 proc.) vyrai. Visi ligoniai buvo patyrę miokardo infarktą, kuris komplikavosi kardiogeniniu šoku.
Rezultatai. Nustatėme, kad intraaortinės kontrapulsacijos metu dažniausiai pasitaikančios širdinės kilmės komplikacijos buvo prieširdžių virpėjimas ir asistolija. Dažniausiai pasitaikanti neširdinės kilmės komplikacija -ūminis inkstų nepakankamumas. Perkutaninių vainikinių arterijų intervencija (PVAI) sėkmingai atlikta 47 (81 proc.) ligoniams, nesėkmingai -11 (19 proc.) ligonių. Buvo pastebėta teigiama PVAI įtaka ligonių baigtims. Ligoniams, kuriems atlikta PVAI, nustatytas mažesnis mirštamumo rodiklis lyginant su tais, kuriems procedūra nebuvo atlikta, atitinkamai -33 proc. ir 83 proc., p=0,003. Tiems, kuriems procedūra nebuvo atlikta, taip pat rečiau užfi ksuota ūminio inkstų nepakankamumo atvejų, atitinkamai -28 proc. ir 67
